A Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
Completed · Phase 2
Conditions studied: Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma
In brief
This is a Phase 2 study to assess the efficacy of SB1518 in the treatment of patients with advanced lymphoid malignancies including Hodgkin Lymphoma, Mantle Cell Lymphoma and Indolent Lymphoma (follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma and small lymphocytic lymphoma).
Key facts
- Study ID
- NCT01263899
- Run by
- S*BIO
- People needed
- 28
- Starts
- 2010-12-01
- Expected to finish
- 2012-02-01
- Last updated by the study team
- 2012-04-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with histologically documented diagnosis of one of the following lymphoid malignancies:
- Hodgkin Lymphoma;
- Mantle Cell Lymphoma;
- Indolent Lymphoma (including follicular lymphoma, lymphoplasmacytic lymphoma, marginal zone lymphoma and small lymphocytic lymphoma);
- Patients must have received at least one prior treatment regimen; patients with Hodgkin Lymphoma must have received an autologous stem cell transplant, refused or been deemed ineligible for stem cell transplant;
- Able to understand and willing to sign the informed consent form.
You may not qualify if…
- Any histology other than Hodgkin Lymphoma, Mantle Cell Lymphoma or Indolent Lymphoma;
- History of or active Central Nervous System (CNS) malignancy;
- Active graft-versus-host disease (GVHD);
Where it is running
- University of Nebraska Medical Center — Omaha, Nebraska, United States
- Weill Medical College of Cornell — New York, New York, United States
- University of Rochester James P. Wilmot Cancer Center — Rochester, New York, United States
- MD Anderson Cancer Canter — Houston, Texas, United States
- University of British Columbia — Vancouver, British Columbia, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.